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to the possibility of induced artifacts or loss of information 
that we observed, a visual comparison of each MAR scan with 
the original scan is performed, and the HU values in the 
artifact-reduced area are spot checked for reasonability 
relative to known tissue HU values. Future studies will 
investigate the impact of this type of MAR on contouring 
variability and accuracy. 
 
 
 
Figure 1: Example of a plan for a patient with bladder cancer 
and double hip prostheses without (top) and with (bottom) 
MAR, where the PTV identical in both images (colorwash 15-
68 Gy). In the top image, the dose was calculated after 
manual override of artifact to 0 HU. The mean dose to the 
PTV was 63.8 Gy and 64.0 Gy, respectively. 
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Purpose or Objective: To assess the dosimetric accuracy of 
CT-substitute attenuation correction (AC) maps generated 
from existent clinical MR data for radiation treatment 
planning in glioma patients. 
 
Material and Methods: CT substitute AC maps were obtained 
with Statistical Parametric Software (SPM) software applied 
on 3D T1-weighted Inversion Recovery scans (IT 650 ms; 
TR/TE 4.6/2.0 ms). Three probability maps (PM) were 
obtained: air, tissue and bone. To derive corresponding AC 
maps, air-PM was multiplied by -1000, tissue-PM by 30 and 
bone-PM by 1000 and 300 when the probability for bone 
tissue was >0.8 and <0.8, respectively. A composite AC map 
(MR-based CT) was obtained by summing up all the PM 
multiplied by the aforementioned values. Difference in bone 
between clinical CT and MR-based CT was quantified with the 
Dice Similarity Coefficient (DSC). 
MR-based CT were read into Eclipse Treatment Planning 
System (Varian Medical Systems, Palo Alto CA) and clinical 
Volumetric Modulated Arc Therapy (VMAT) plans were 
recalculated with a 0.1 cm dose calculation grid size for 10 
patients. All plans were calculated with Accuros XB dose 
calculation algorithm for a prescription dose of 60 Gy and 
consisted of two arcs with a different collimator angle to 
minimize tongue and groove effect. 
Differences between both plans were assessed according to 
the D2%, D98%, Dmean and γ-index (3%/3mm) for the 
relevant structures: CTV, PTV, brainstem and optical system. 
 
Results: MR-based CTs were generated for 10 patients using 
SPM software and current clinical MR examinations without 
the need of adding extra sequences to the clinical protocol. 
Bone segmentation exhibited an average DSC of 0.81±0.07 
(SD) between clinical CT and MR-based CT segmentation, 
detecting SPM software less bone than in the clinical CT. 
Recalculated VMAT plans on the MR-based CTs exhibited a 
very good agreement with the clinical plans. Average Dmean, 
D2% and D98% for CTV and PTV differed less than 0.5%. 
Difference in D2% for brainstem and optical system between 
the clinical plans and recalculated plans using an MR-based 
CT were 0.4% and 1.1%, respectively. All metrics were found 
not significantly different (p>0.05) from the clinically 
approved plans. 
3D-dose distributions for the CTV and PTV in MR-based plans 
resulted in γ-passing rates higher than 0.99±0.01 for both 
structures. Average γ-value for CTV and PTV was 0.16±0.08 
and 0.23±0.16, respectively. 
 
Conclusion: MR-based CTs were generated using SPM 
software on 3D MR T1-weighted Inversion Recovery scans with 
more than 80% agreement for bone segmentation. MR-based 
VMAT plans exhibited a very good agreement with the clinical 
plans based on a standard CT as measured by the D2%, D98%, 
Dmean and γ-index metrics for all relevant structures. 
It is feasible a clinical workflow for radiation treatment 
planning purposes for glioma patients based only on MR 
without the need of CT or adding additional MR sequences to 
the clinical protocol for bone segmentation. 
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Purpose or Objective: Current clinical practise in 
radiotherapy CT scanning of lung tumours takes into account 
movement due to breathing. However, the accuracy of used 
scan protocols is usually validated for phantoms with fairly 
regular movements, and the effects of breathing irregularity 
are unclear. Aim of this study is to establish the impact of 
clinically occurring irregularities on delineated treatment 
volumes determined using 4DCT images. 
 
Material and Methods: Respiratory patterns, as recorded 
during CT scanning, were (anonymously) obtained for 50 lung 
